Suppression of HER2/HER3-Mediated Growth of Breast Cancer Cells with Combinations of GDC-0941 PI3K Inhibitor, Trastuzumab, and PertuzumabEvelyn Yao, Klaus P. Hoeflich, Wei Zhou et al.|Clinical Cancer Research|2009Cited by 124
Structure-Guided Design of Group I Selective p21-Activated Kinase InhibitorsJames J. Crawford, Joachim Rudolph, Wendy Lee et al.|Journal of Medicinal Chemistry|2015Cited by 42
Discovery of a Potent (4<i>R</i>,5<i>S</i>)-4-Fluoro-5-methylproline Sulfonamide Transient Receptor Potential Ankyrin 1 Antagonist and Its Methylene Phosphate Prodrug Guided by Molecular ModelingHuifen Chen, Anthony A. Estrada, Matthew Volgraf et al.|Journal of Medicinal Chemistry|2018Cited by 39
050 Evaluation of 3 month data for the use of erenumab for chronic migraine in GlasgowKrishna Dani, Alok Tyagi, Lesley Murray et al.|Journal of Neurology Neurosurgery & Psychiatry|2022Cited by 0
P18.43.A THE APPROACH TRIAL (ANALYSIS OF PROTON VS PHOTON RADIOTHERAPY IN OLIGODENDROGLIOMA AND ASSESSMENT OF COGNITIVE HEALTH): OPEN AND RECRUITING IN THE UKLesley Murray, Susan Short, Sarah Brown et al.|Neuro-Oncology|2024Cited by 0